-

Shareholder Alert: Robbins LLP Announces a Shareholder Has Sued Nikola Corporation (NKLA)

SAN DIEGO & PHOENIX--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Nikola Corporation (NASDAQ: NKLA) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between June 4, 2020 and September 9, 2020. Nikola operates as an integrated zero emissions transportation systems provider.

If you suffered a loss due to Nikola's misconduct, click here.

Nikola Corporation (NKLA) Accused of Misleading Shareholders

According to the complaint, during the class period, Trevor Milton, chairman and founder, repeatedly falsely touted the strength of Nikola's financial, technological, and operational profile. On September 10, 2020, Hindenburg Research published a report entitled “Nikola: How to Parlay an Ocean of Lies into a Partnership with the Largest Auto OEM in America.” Hindenburg alleged that Milton had misled partners into signing agreements by falsely claiming to have extensive proprietary technology. Among other things, the report claimed that Milton had staged a video of Nikola’s semi-truck cruising down a road by filming the truck rolling down a hill and that, despite claiming Nikola designs all key components in house, the Company appears to simply be buying or licensing them from third-parties. On this news, Nikola's stock dropped 11.33% to close at $37.57. Shortly thereafter, the Securities Exchange Commission and Department of Justice announced investigations against Nikola. On this news, the stock dropped to close at $32.83 on September 15, 2020.

If you purchased shares of Nikola Corporation (NKLA) between June 4, 2020 and September 9, 2020, you have until November 16, 2020, to ask the court to appoint you lead plaintiff.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Nikola Corporation settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the AeroVironment, Inc. Class Action  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired AeroVironment, Inc. (NASDAQ: AVAV) securities between June 25, 2025 and March 10, 2026. AeroVironment operates as a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robb...

LKQ Corporation Class Action Reminder - Robbins LLP Encourages LKQ Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired LKQ Corporation (NASDAQ: LKQ) common stock between February 27, 2023 and July 23, 2025. LKQ is a global distributor of alternative collision replacement parts, recycled engines, and other vehicle components for the repair of automobiles.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.Wha...

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...
Back to Newsroom